EdgarLookup

SUI Group Holdings Ltd. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that SUI Group Holdings Ltd. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-6825%
Profit Margin
Net income ÷ revenue
-139.8%
Return on Assets
Net income ÷ assets
0.12x
Debt-to-Equity
Total liabilities ÷ equity
+18.1%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.90M Feb 27, 2026
FY2025 Dec 31, 2024 $3.30M Feb 27, 2026
FY2011 Dec 31, 2011 $12.4K Feb 29, 2012
FY2011 Dec 31, 2010 $3.0K Feb 29, 2012

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2011 Dec 31, 2011 ($49.4K) Feb 29, 2012
FY2011 Dec 31, 2010 ($9.1K) Feb 29, 2012

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($266.08M) Feb 27, 2026
FY2011 Dec 31, 2011 ($126.8K) Feb 29, 2012
FY2011 Dec 31, 2010 ($148.6K) Feb 29, 2012
FY2011 Dec 31, 2009 ($167.4K) Feb 29, 2012
FY2011 Dec 31, 2008 ($282.7K) Feb 29, 2012
FY2011 Dec 31, 2007 ($199.6K) Feb 29, 2012
FY2011 Dec 31, 2006 ($43.1K) Feb 29, 2012

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($264.04M) Feb 27, 2026
FY2025 Dec 31, 2024 $1.59M Feb 27, 2026
FY2011 Dec 31, 2011 ($107.9K) Feb 29, 2012
FY2011 Dec 31, 2010 ($139.4K) Feb 29, 2012

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2011 Dec 31, 2011 $107.9K Feb 29, 2012
FY2011 Dec 31, 2010 $130.3K Feb 29, 2012

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($8.24M) Feb 27, 2026
FY2025 Dec 31, 2024 $5.65M Feb 27, 2026
FY2024 Dec 31, 2023 ($1.14M) Mar 10, 2025
FY2023 Dec 31, 2022 ($4.89M) Apr 2, 2024
FY2022 Dec 31, 2021 ($1.89M) May 22, 2023
FY2021 Dec 31, 2020 ($2.46M) Mar 14, 2022
FY2011 Dec 31, 2011 ($65.3K) Feb 29, 2012
FY2011 Dec 31, 2010 ($62.4K) Feb 29, 2012

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $190.36M Feb 27, 2026
FY2025 Dec 31, 2024 $20.47M Feb 27, 2026
FY2024 Dec 31, 2023 $19.11M Mar 10, 2025
FY2023 Dec 31, 2022 $18.73M Apr 2, 2024
FY2022 Dec 31, 2021 $16.70M May 22, 2023
FY2021 Dec 31, 2020 $12.51M Mar 14, 2022
FY2011 Dec 31, 2011 $22.8K Feb 29, 2012
FY2011 Dec 31, 2010 $3.1K Feb 29, 2012

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $20.62M Feb 27, 2026
FY2025 Dec 31, 2024 $715.4K Feb 27, 2026
FY2024 Dec 31, 2023 $516.4K Mar 10, 2025
FY2023 Dec 31, 2022 $863.2K Apr 2, 2024
FY2022 Dec 31, 2021 $3.28M May 22, 2023
FY2021 Dec 31, 2020 $870.0K Mar 14, 2022
FY2011 Dec 31, 2011 $217.7K Feb 29, 2012
FY2011 Dec 31, 2010 $119.1K Feb 29, 2012

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $169.74M Feb 27, 2026
FY2025 Dec 31, 2024 $19.76M Feb 27, 2026
FY2025 Dec 31, 2023 $18.59M Feb 27, 2026
FY2024 Dec 31, 2022 $17.87M Mar 10, 2025
FY2023 Dec 31, 2021 $13.41M Apr 2, 2024
FY2022 Dec 31, 2020 $11.64M May 22, 2023
FY2021 Dec 31, 2019 $10.07M Mar 14, 2022
FY2011 Dec 31, 2011 ($194.9K) Feb 29, 2012
FY2011 Dec 31, 2010 ($116.0K) Feb 29, 2012
FY2011 Dec 31, 2009 ($38.0K) Feb 29, 2012

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($262.13M) Feb 27, 2026
FY2025 Dec 31, 2024 ($1.16M) Feb 27, 2026
FY2024 Dec 31, 2023 ($1.16M) Mar 10, 2025
FY2023 Dec 31, 2022 ($1.16M) Apr 2, 2024
FY2022 Dec 31, 2021 ($1.16M) May 22, 2023
FY2021 Dec 31, 2020 ($1.16M) Mar 14, 2022

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2024 $6.03M Feb 27, 2026
FY2024 Dec 31, 2023 $376.0K Mar 10, 2025
FY2023 Dec 31, 2022 $1.09M Apr 2, 2024
FY2022 Dec 31, 2021 $1.94M May 22, 2023
FY2021 Dec 31, 2020 $5.44M Mar 14, 2022

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (6) Feb 27, 2026
FY2025 Dec 31, 2024 0 Feb 27, 2026
FY2023 Dec 31, 2023 0 Apr 2, 2024
FY2023 Dec 31, 2022 0 Apr 2, 2024
FY2022 Dec 31, 2021 0 May 22, 2023
FY2021 Dec 31, 2020 0 Mar 14, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (6) Feb 27, 2026
FY2025 Dec 31, 2024 0 Feb 27, 2026
FY2021 Dec 31, 2021 0 Mar 14, 2022
FY2021 Dec 31, 2020 0 Mar 14, 2022

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 76.80M Feb 27, 2026
FY2025 Dec 31, 2024 6.39M Feb 27, 2026
FY2024 Dec 31, 2023 6.39M Mar 10, 2025
FY2024 Dec 31, 2022 6.19M Mar 10, 2025
FY2024 Dec 31, 2021 4.80M Mar 10, 2025
FY2024 Dec 31, 2020 4.79M Mar 10, 2025
FY2023 Dec 31, 2019 4.92M Apr 2, 2024
FY2021 Sep 30, 2019 11.07M Mar 14, 2022
FY2022 Dec 31, 2018 4.92M May 22, 2023
FY2021 Sep 30, 2018 11.07M Mar 14, 2022

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $0 May 22, 2023
FY2022 Dec 31, 2021 $1.62M May 22, 2023